Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-08-21

Clinical Trial Update: Fingolimod for Type 2 Diabetes Mellitus [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating fingolimod for Type 2 diabetes mellitus is currently recruiting, sponsored by the General Hospital of Shenyang Military Regi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fingolimod (fingolimod)

Snippet

Sponsor: General Hospital of Shenyang Military Region | Conditions: Diabetes Mellitus, Type 2 | Phase 4 | Status: RECRUITING